Search
Diabetic Macular Edema Paid Clinical Trials in Wisconsin
A listing of 1 Diabetic Macular Edema clinical trials in Wisconsin actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
1 - 1 of 1
Match to Clinical Trials
Access to cutting-edge treatments
Latest clinical trials
Find trials in your area
Search by Name
Filter by Condition
Diabetic Macular Edema
Filter by Age
Filter by Type
Gender
Type of Study
Clinical Trial Phase
The state of Wisconsin currently has 1 active clinical trials seeking participants for Diabetic Macular Edema research studies. These trials are conducted in various cities, including Milwaukee, Madison, Green Bay and Marshfield.
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Featured Trial
Diabetic Peripheral Neuropathy Clinical Study
Recruiting
If you struggle with chronic nerve pain in your legs due to diabetes (diabetic peripheral neuropathy, or DPN), Vertex Pharmaceuticals is conducting research studies that may be an option.
Conditions:
Diabetes Mellitus
Type 2
Diabetes
Diabetes Mellitus
Type 2 Diabetes
Featured Trial
Type 2 Diabetes Clinical Trial
Recruiting
Can changing your breakfast improve your type 2 diabetes? If you have an HbA1C of 7.0% or higher, you are invited to participate in an online study at the University of Michigan.
Conditions:
Type 2 Diabetes
Diabetes Mellitus Type 2 in Obese
Diabetes Type Two
Type 2 Diabetes Mellitus
Diabete Type 2
Featured Offer
Lose Weight with GLP-1 Medications
Recruiting
Policy Lab has partnered with CareGLP to offer trusted access to GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.
Conditions:
Overweight
Overweight and Obesity
Obesity
Weight Loss
Morbid Obesity
Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME)
Recruiting
A Phase 1 study to assess the safety and efficacy of OCU200 for center-involved diabetic macular edema
Gender:
ALL
Ages:
18 years and above
Trial Updated:
03/17/2025
Locations: Gundersen Health System, La Crosse, Wisconsin
Conditions: Center Involved Diabetic Macular Edema, Diabetic Macular Edema
1 - 1 of 1